Advanced Catheter Therapies

Advanced Catheter Therapies, Inc. (ACT) is an early stage research and development medical device company with a portfolio of innovative catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis.

ACT has initially focused its resources on the problem of restenosis and is developing the game-changing Occlusion Perfusion Catheter™ (OPC™). The OPC is a multi‐lumen balloon catheter designed to temporarily occlude a specific region from blood flow to allow the local delivery of therapeutic agents to the peripheral and coronary vasculature.

Also in the development pipeline are devices to improve endovascular debulking procedures (the clearing of blocked blood vessels).

News

Advanced Catheter Therapies Completes Series B Funding
with Toray Industries, Inc.

 
CHATTANOOGA, March 17, 2015 – Advanced Catheter Therapies, Inc. (ACT) announced today that it has completed its $4.5M Series B preferred equity financing round through a strategic investment by TAM Ventures, Limited (TAMV), a subsidiary and a corporate venturing arm of Toray Industries, Inc. (TORAY) in Tokyo, Japan.
 
ACT is a research and development medical device company with a portfolio of innovative catheter technologies addressing vascular disease and targeted endovascular drug delivery. The company recently received the first limited shipment of its lead product, the Occlusion Perfusion Catheter™ (OPC), which is patented and 510(k) cleared, that will be used to support clinical trials and a targeted test market release.

Read more